← Back to Clinical Trials
Recruiting NCT06415890

NCT06415890 Effect of 4-7-8 Breathıng Technıque on Shoulder Paın and Respıratory Functıon Tests After Laparoscopıc Cholesectectomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06415890
Status Recruiting
Phase
Sponsor Mustafa Kemal University
Condition Laparoscopic Cholecystectomy
Study Type INTERVENTIONAL
Enrollment 98 participants
Start Date 2024-08-25
Primary Completion 2025-04-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
4-7-8 Breathing Technique

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 98 participants in total. It began in 2024-08-25 with a primary completion date of 2025-04-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study was planned as a randomized controlled clinical trial to determine the effect of 4-7-8 breathing technique on shoulder pain and pulmonary function tests after laporoscopic cholecystectomy. A sample of 96 patients will be randomly assigned to the study and control groups. The study group will be administered the 4-7-8 breathing technique after LK, while the control group will be given routine care of the ward. Shoulder pain and pulmonary function tests will be measured in the first 24 hours and at discharge. The data obtained will be analyzed by appropriate statistical methods.

Eligibility Criteria

Inclusion Criteria: * Undergoing elective laparoscopic cholecystectomy, * Admitted to the clinic at least 2 hours before the surgical procedure, * Open to communication and cooperation, * Written and verbal permission to participate in the study was obtained, * Conscious, oriented and cooperative, * No cognitive and mental problems, * Speaks and understands Turkish, * American Society of Anesthesiologists (ASA) classification scores of I and II, * Hospitalized at least one night after surgical intervention, * Patients aged 18 years and older will be included in the study. Exclusion Criteria: * Undergoing emergency laparoscopic cholecystectomy, * Open cholecystectomy, * Not admitted to the clinic at least 2 hours before the surgical procedure, * Not open to communication and cooperation, * Written and verbal permission to participate in the research could not be obtained, * Unconscious, disoriented and uncooperative, * Cognitively and mentally impaired, * Speaking Turkish but not understanding it, * Discharged on the same day after surgical intervention, * ASA score III and above, * Patients aged 18 years and younger will not be included in the study.

Contact & Investigator

Central Contact

Ayşe Nur SERBEST BAZ

✉ aysenurserbest@hotmail.com

📞 03262213317

Principal Investigator

Gülay ALTUN UĞRAŞ

STUDY DIRECTOR

Mersin University

Frequently Asked Questions

Who can join the NCT06415890 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Laparoscopic Cholecystectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06415890 currently recruiting?

Yes, NCT06415890 is actively recruiting participants. Contact the research team at aysenurserbest@hotmail.com for enrollment information.

Where is the NCT06415890 trial being conducted?

This trial is being conducted at Hatay, Turkey (Türkiye).

Who is sponsoring the NCT06415890 clinical trial?

NCT06415890 is sponsored by Mustafa Kemal University. The principal investigator is Gülay ALTUN UĞRAŞ at Mersin University. The trial plans to enroll 98 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology